TY  - RPRT
TI  - A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
AU  - T Betts
AU  - T Waegemans
AU  - P Crawford
PY  - 2000
DO  - 10.1053/seiz.2000.0380
UR  - https://pubmed.ncbi.nlm.nih.gov/10845730/
ID  - 10845730
ER  -